Full Text
Diabetes mellitus is a chronic metabolic disorder that has become one of the most significant global health challenges of the twenty-first century. The increasing prevalence of diabetes has been accompanied by a substantial rise in long-term complications affecting multiple organ systems. Among these complications, diabetic peripheral neuropathy represents one of the most common and clinically important neurological manifestations.
Diabetic peripheral neuropathy is characterized by progressive damage to peripheral nerves resulting from chronic metabolic and vascular abnormalities associated with diabetes. The disorder affects sensory, motor, and autonomic nerve fibers to varying degrees and may lead to significant functional impairment. Patients frequently experience symptoms such as numbness, tingling sensations, burning pain, muscle weakness, sensory loss, and impaired balance. In advanced cases, neuropathy may contribute to foot ulceration, infection, and lower-limb amputation.
The pathogenesis of diabetic peripheral neuropathy is complex and multifactorial. Persistent hyperglycemia induces metabolic alterations that promote oxidative stress, mitochondrial dysfunction, accumulation of advanced glycation end products, and activation of inflammatory pathways. These mechanisms contribute to neuronal injury and microvascular impairment, resulting in reduced nerve perfusion and progressive axonal degeneration.
Neurophysiological abnormalities often develop before overt clinical symptoms become apparent. Consequently, objective assessment of nerve function plays a crucial role in early diagnosis. Nerve conduction studies remain the gold standard for evaluating peripheral nerve integrity and detecting subclinical neuropathic changes. These investigations provide valuable information regarding conduction velocity, amplitude, and latency parameters, allowing precise characterization of neuropathic involvement.
Clinical manifestations of diabetic peripheral neuropathy vary considerably among patients. Distal symmetric polyneuropathy is the most common form and typically presents with a stocking-and-glove distribution of sensory deficits. However, focal neuropathies, autonomic neuropathies, and proximal neuropathic syndromes may also occur. The heterogeneity of clinical presentation often complicates diagnosis and requires comprehensive neurological assessment.
The burden of diabetic peripheral neuropathy extends beyond physical symptoms. Chronic pain, sleep disturbances, impaired mobility, depression, and reduced social participation significantly affect quality of life. Furthermore, neuropathy contributes substantially to healthcare costs through increased hospitalization rates and management of diabetic foot complications.
Advances in diagnostic technology have improved understanding of the neurophysiological mechanisms underlying diabetic neuropathy. Modern electrophysiological techniques, quantitative sensory testing, and neuroimaging methods allow earlier detection of nerve dysfunction and facilitate monitoring of disease progression.
Management of diabetic peripheral neuropathy requires a comprehensive approach addressing both underlying metabolic disturbances and symptomatic manifestations. Strict glycemic control remains the cornerstone of prevention and treatment. Additional therapeutic strategies include pharmacological management of neuropathic pain, lifestyle modification, physical rehabilitation, and prevention of foot-related complications.
Despite significant progress in diabetes care, diabetic peripheral neuropathy continues to represent a major cause of disability worldwide. Early recognition of clinical and neurophysiological abnormalities is essential for timely intervention and prevention of irreversible nerve damage.
The aim of this study was to investigate the clinical and neurophysiological features of diabetic peripheral neuropathy and to evaluate modern approaches to its diagnosis, treatment, and long-term management.
2. Materials and Methods
This study was conducted from 2024 to 2025 at the Neurology Department of Samarkand State Medical University and affiliated clinical centers. A total of 120 patients diagnosed with type 1 or type 2 diabetes mellitus participated in the investigation. The age of participants ranged from 35 to 75 years. Patients were divided into groups according to disease duration, glycemic control status, and severity of neuropathic manifestations.
All participants underwent comprehensive clinical and neurological evaluation. Medical history was collected with special attention to diabetes duration, treatment adherence, associated cardiovascular risk factors, smoking status, and previous neurological complications. Physical examination included assessment of muscle strength, tendon reflexes, sensory function, coordination, and gait stability.
Neurological assessment focused on symptoms commonly associated with diabetic peripheral neuropathy, including numbness, paresthesia, burning sensations, pain, muscle weakness, and balance disturbances. Standardized neuropathy scoring systems were applied to evaluate symptom severity and functional impairment.
Neurophysiological investigations were performed using nerve conduction studies. Motor and sensory nerve conduction velocities, distal latencies, and action potential amplitudes were measured in upper and lower extremities. Electromyography was conducted in selected cases to assess neuromuscular involvement and identify axonal or demyelinating changes.
Laboratory examinations included fasting blood glucose, glycated hemoglobin (HbA1c), lipid profile, renal function tests, and inflammatory markers. These parameters were analyzed to determine their relationship with neuropathy severity and progression.
Treatment strategies included optimization of glycemic control, pharmacological management of neuropathic pain, vitamin supplementation, physiotherapy, lifestyle modification, and patient education. Follow-up assessments were conducted over a twelve-month observation period.
Clinical examination revealed that sensory disturbances were the most frequently reported manifestations of diabetic peripheral neuropathy. Numbness, tingling sensations, and burning pain were predominantly localized to the feet and lower legs. Many patients described progressive worsening of symptoms during nighttime hours, resulting in sleep disturbances and reduced quality of life.
Neurological evaluation demonstrated decreased vibration perception, impaired temperature sensation, and diminished ankle reflexes in a significant proportion of participants. Advanced cases exhibited loss of protective sensation, increasing the risk of foot injury and ulcer formation.
Motor involvement was identified in patients with long-standing diabetes and severe neuropathy. These individuals demonstrated distal muscle weakness, reduced endurance during walking, and impaired balance. Functional limitations were more pronounced among patients with poor glycemic control and longer disease duration.
Neurophysiological studies revealed significant abnormalities in nerve conduction parameters. Reduced sensory nerve action potential amplitudes and slowed conduction velocities were among the most common findings. Lower extremity nerves were affected more frequently and more severely than upper extremity nerves, reflecting the typical length-dependent pattern of diabetic neuropathy.
Patients with elevated HbA1c levels exhibited greater neurophysiological impairment compared with individuals maintaining satisfactory glycemic control. Statistical analysis demonstrated a significant correlation between chronic hyperglycemia and severity of nerve dysfunction.
Implementation of comprehensive management strategies resulted in measurable clinical improvement. Better glycemic control was associated with stabilization of neuropathic progression and reduction in symptom severity. Pharmacological treatment significantly alleviated neuropathic pain and improved daily functioning in many patients.
Physical rehabilitation programs contributed to enhanced mobility, balance, and muscle performance. Patients participating actively in exercise and physiotherapy interventions demonstrated greater functional improvement than those relying solely on medication.
The findings of this study confirm that diabetic peripheral neuropathy remains one of the most prevalent and disabling complications of diabetes mellitus. The disorder develops gradually and often remains undetected until significant nerve damage has occurred. Consequently, early identification through clinical and neurophysiological assessment is essential for preventing irreversible neurological deficits.
The predominance of sensory symptoms observed in this investigation is consistent with the characteristic pattern of diabetic neuropathy. Small and large sensory fibers are particularly vulnerable to chronic metabolic disturbances, resulting in progressive impairment of sensation and increased susceptibility to injury.
Neurophysiological findings provided objective evidence of peripheral nerve dysfunction and demonstrated the value of nerve conduction studies in diagnostic evaluation. These investigations are particularly useful for detecting subclinical abnormalities and monitoring disease progression over time.
The observed relationship between poor glycemic control and neuropathy severity highlights the central role of hyperglycemia in disease pathogenesis. Persistent elevation of blood glucose contributes to oxidative stress, endothelial dysfunction, inflammatory activation, and microvascular compromise, ultimately leading to nerve injury.
Modern management of diabetic peripheral neuropathy extends beyond symptom control. Comprehensive care requires optimization of metabolic status, prevention of complications, rehabilitation interventions, and patient education. Multidisciplinary approaches involving neurologists, endocrinologists, rehabilitation specialists, and diabetes educators provide the greatest potential for improving long-term outcomes.
The beneficial effects of rehabilitation observed in this study emphasize the importance of non-pharmacological interventions. Regular physical activity enhances circulation, improves neuromuscular function, and contributes to maintenance of independence and mobility.
Despite advances in treatment, complete reversal of established neuropathy remains challenging. Therefore, prevention through early diagnosis and effective diabetes management continues to represent the most effective strategy for reducing disease burden.
Future research should focus on identification of novel biomarkers, development of neuroprotective therapies, and investigation of regenerative treatment approaches capable of restoring damaged peripheral nerves.
Diabetic peripheral neuropathy is a common and progressive neurological complication of diabetes mellitus characterized by significant clinical and neurophysiological abnormalities. Sensory disturbances, neuropathic pain, motor impairment, and reduced quality of life constitute the principal manifestations of the disorder.
Neurophysiological investigations provide valuable diagnostic information and allow objective assessment of nerve dysfunction. The severity of neuropathic changes is closely associated with disease duration and long-term glycemic control.
Comprehensive management strategies involving strict metabolic control, pharmacological therapy, rehabilitation programs, and patient education contribute significantly to symptom reduction and functional improvement. Early diagnosis and multidisciplinary intervention remain essential for preventing progression, reducing disability, and improving long-term clinical outcomes in patients with diabetic peripheral neuropathy.
[1] Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019;5(1):41.
[2] Pop-Busui R, Boulton AJM, Feldman EL, et al. Diabetic neuropathy: A position statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136–154.
[3] Tesfaye S, Boulton AJM, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285–2293.
[4] Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012;11(6):521–534.
[5] Sloan G, Selvarajah D, Tesfaye S. Pathogenesis, diagnosis and clinical management of diabetic neuropathy. BMJ. 2021;374:n1786.
[6] Vinik AI, Nevoret ML, Casellini C, Parson H. Diabetic neuropathy. Endocrinol Metab Clin North Am. 2013;42(4):747–787.
[7] Dyck PJ, Albers JW, Andersen H, et al. Diabetic polyneuropathies: clinical and neuropathological aspects. Diabetes Metab Res Rev. 2011;27(7):620–628.
[8] Malik RA. Current understanding of the pathophysiology of diabetic neuropathy. Neurol Clin. 2020;38(4):787–799.
[9] Selvarajah D, Kar D, Khunti K, et al. Diabetic peripheral neuropathy: advances in diagnosis and screening. BMJ. 2019;366:l5405.
[10] Perkins BA, Bril V. Electrophysiologic testing in diabetic neuropathy. Handb Clin Neurol. 2014;126:235–248.
[11] England JD, Gronseth GS, Franklin G, et al. Evaluation of distal symmetric polyneuropathy: role of laboratory and neurophysiological studies. Neurology. 2009;72(2):177–184.
[12] Ang L, Jaiswal M, Martin C, Pop-Busui R. Glucose control and diabetic neuropathy. Curr Diab Rep. 2014;14(9):528.
[13] Ziegler D, Papanas N, Vinik AI, Shaw JE. Epidemiology of diabetic polyneuropathy. Handb Clin Neurol. 2014;126:3–22.
[14] American Diabetes Association. Standards of Care in Diabetes—2025. Diabetes Care. 2025;48(Suppl 1):S1–S350.
[15] International Diabetes Federation. IDF Diabetes Atlas. 11th ed. Brussels: IDF; 2024.
[16] World Health Organization. Diabetes Fact Sheet. Geneva: WHO; 2025.
[17] Bril V, England J, Franklin GM, et al. Evidence-based guideline: treatment of painful diabetic neuropathy. Neurology. 2011;76(20):1758–1765.
[18] Tesfaye S, Selvarajah D. Advances in epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev. 2012;28(Suppl 1):8–14.
[19] Med1.uz. Diabetik periferik neyropatiya: klinik belgilari va diagnostikasi. Available from: https://med1.uz/articles/nevrologiya/diabetik-periferik-neyropatiya
[20] Med1.uz. Qandli diabetning nevrologik asoratlari. Available from: https://med1.uz/articles/nevrologiya/diabet-asoratlari
[21] Med1.uz. Elektroneyromiografiya va periferik nerv tizimi kasalliklari. Available from: https://med1.uz/articles/diagnostika/enmg
[22] Med1.uz. Diabetik polineyropatiyada zamonaviy diagnostika usullari. Available from: https://med1.uz/articles/nevrologiya/polineyropatiya-diagnostika
[23] Med1.uz. Diabetik neyropatiyada glikemik nazoratning ahamiyati. Available from: https://med1.uz/articles/endokrinologiya/glikemik-nazorat
[24] Med1.uz. Qandli diabet va periferik nerv tizimi zararlanishlari. Available from: https://med1.uz/articles/endokrinologiya/periferik-nervlar
[25] Med1.uz. Nevrologik bemorlarni klinik va instrumental baholash. Available from: https://med1.uz/articles/nevrologiya/klinik-baholash
[26] Med1.uz. Diabetik neyropatiyani davolash va profilaktika qilishning zamonaviy usullari. Available from: https://med1.uz/articles/nevrologiya/neyropatiya-davolash